Symbol="PTGX"
AssetType="Common Stock"
Name="Protagonist Therapeutics Inc"
Description="Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California."
CIK="1377121"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1190827000"
EBITDA="-145250000"
PERatio="None"
PEGRatio="0"
BookValue="4.202"
DividendPerShare="0"
DividendYield="0"
EPS="-2.34"
RevenuePerShareTTM="0.017"
ProfitMargin="0"
OperatingMarginTTM="-170.29"
ReturnOnAssetsTTM="-0.311"
ReturnOnEquityTTM="-0.541"
RevenueTTM="859000"
GrossProfitTTM="26581000"
DilutedEPSTTM="-2.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="39.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="13.27"
PriceToBookRatio="1.925"
EVToRevenue="5.84"
EVToEBITDA="-1.604"
Beta="1.937"
num_52WeekHigh="30.1"
num_52WeekLow="7.24"
num_50DayMovingAverage="26.18"
num_200DayMovingAverage="16.61"
SharesOutstanding="57251000"
DividendDate="None"
ExDividendDate="None"
symbol="PTGX"
open="20.53"
high="21.96"
low="20.50"
price="21.39"
volume="1606002.00"
latest_trading_day="2023-07-13"
previous_close="20.44"
change="0.95"
change_percent="4.6722%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="8"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="92"
Volume_recent_avg="1555532"
Change_recent_avg="0.03"
Delta_recent_avg="1.39"
Variance_recent_avg="0.69"
Change_ratio_recent_avg="0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="92"
Aroon_momentum_negative="8"
image_negative_thumbnail_id_1="100"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0076.jpeg"
image_negative_thumbnail_id_2="1088"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="580"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="660"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_positive_thumbnail_id_2="958"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0120.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
